UAB "Innovative Pharma Baltics" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,752,950 |
| 66,804 |
| 92,285 |
| 92,285 |
| 3,517 |
| 62.63 |
| 5.26 |
| 995,035 |
| 1,309,896 |
| 580,735 |
| 1,910,910 |
| 2024 |
|---|
| 2,626,420 |
| 113,747 |
| 80,890 |
| 80,890 |
| 3,503 |
| 49.84 |
| 3.08 |
| 1,075,924 |
| 1,558,296 |
| 546,059 |
| 2,242,980 |
| 2025 |
|---|
| 2,081,872 |
| 106,218 |
| -433,926 |
| -433,926 |
| -22,139 |
| 38.64 |
| -20.84 |
| 641,998 |
| 1,063,649 |
| 357,951 |
| 1,453,932 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 2,081,872 |
| 106,218 |
| -433,926 |
| -433,926 |
| -22,139 |
| 38.64 |
| -20.84 |
| 641,998 |
| 1,063,649 |
| 357,951 |
| 1,453,932 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
2,081,872 €-21 % *
Sales per employee (€)
106,218 €-7 % *
Profit before tax (€)
-433,926 €-636 % *
Net Profit (€)
-433,926 €-636 % *
Profit per employee (€)
-22,139 €-732 % *
Total profitability (%)
38.64 %-22.47 % *
Net profitability (%)
-20.84 %-776.62 % *
Equity (€)
641,998 €-40 % *
Amounts Payable And Liabilities (€)
1,063,649 €-32 % *
Non-current Assets (€)
357,951 €-34 % *
CurrentAssets (€)
1,453,932 €-35 % *
